
首页
Abacavir (sulfate)

产品介绍
产品介绍
产品信息
简单描述
Abacavir is a nucleoside analog and an inhibitor of HIV-1 reverse transcriptase (Ki = 2.1 µM for the wild-type enzyme).1 It inhibits replication of a variety of HIV-1 and HIV-2 strains, including strains resistant to 3'-azido-3'-deoxythymidine (zidovudine; Item No. 15492) or 2',3'-dideoxyinosine (didanosine; Item No. 23715), in HeLa cells stably expressing CD4 (IC50s = 5.8-21 µM). Abacavir inhibits replication of eight HIV-1 clinical isolates in phytohemagglutinin-stimulated isolated human peripheral blood lymphocytes with a mean IC50 value of 0.26 µM. It inhibits hepatitis B virus (HBV) DNA synthesis in HepG2 cells (IC50 = 7 µM) and is also active against human cytomegalovirus (CMV) strain AD169 and the Petaluma strain of feline immunodeficiency virus (FIV) in plaque reduction assays (IC50s = 32 and 0.4 µM, respectively). Formulations containing abacavir have been used in the treatment of HIV infection.WARNING This product is not for human or veterinary use.

商品描述
An antiviral nucleoside analog

分子量
384.4

纯度
≥98%

产品类型
Biochemicals/Antivirals/Nucleoside Reverse Transcriptase Inhibitors (NRTIs)/Nucleotides/Nucleosides/Small Molecule Inhibitors/Reverse Transcriptases

背景
别名
Formal_Name:(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol, monosulfate;Synonyms:1592U89

研究领域
Immunology & Inflammation,Infectious Disease/Viral Diseases/Hepatitis/HIV & AIDS
结构式
NC1=NC(N([C@H]2C=C[C@@H](CO)C2)C=N3)=C3C(NC4CC4)=N1.O=S(O)(O)=O

分子式
C14H18N6O • H2SO4

CAS号
216699-07-9

制备和贮存
保存
≥ 4 years

溶解方法
DMSO: 0.15 mg/ml
PBS (pH 7.2): 1 mg/ml

保存方式
-20°C
文献
文献
1.Choo, H.,Chong, Y. and Chu, C.K. The role of 2',3'-unsaturation on the antiviral activity of anti-HIV nucleosides against 3TC-resistant mutant (M184V). Bioorganic & Medicinal Chemistry Letters 13(12), 1993-1996 (2003).
2.Saag, M.S. Initiation of antiretroviral therapy: Implications of recent findings. Top.HIV Med. 12(3), 83-88 (2004).
3.Phillips, E.J. and Mallal, S.A. Pharmacogenetics of drug hypersensitivity. Pharmacogenomics 11(7), 973-987 (2010).
2.Saag, M.S. Initiation of antiretroviral therapy: Implications of recent findings. Top.HIV Med. 12(3), 83-88 (2004).
3.Phillips, E.J. and Mallal, S.A. Pharmacogenetics of drug hypersensitivity. Pharmacogenomics 11(7), 973-987 (2010).

参考图片
声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。